药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Hepatitis A Vaccine
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Bacillus calmette-guerin substrain connaught live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Typhoid Vi polysaccharide vaccine
The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Clostridium tetani toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Bacillus calmette-guerin substrain tice live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Varicella Zoster Vaccine (Live/attenuated)
The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rubella virus vaccine
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Prednisolone acetate.